IPOGrid
0001591165
IPO filing research

Innoveren Scientific, Inc.

Surgical & Medical Instruments & Apparatus

follow-on priced 424B4

Innoveren Scientific, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: 424B4 on 2022-02-16.

Filing Timeline

SEC EDGAR
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2022-02-16 · 0001493152-22-004781
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2022-02-14 · 9999999995-22-000460
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2022-02-10 · 0001493152-22-003697
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B2 in the pre-IPO sequence.
2022-02-07 · 0001493152-22-003330
424B2 filed
Prospectus supplement
Prospectus supplement that can carry timing details without itself confirming imminent trading.
Follows EFFECT in the pre-IPO sequence.
2020-08-05 · 0001493152-20-014719
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2020-08-04 · 9999999995-20-002018
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2020-07-31 · 0001493152-20-014263
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B5 in the pre-IPO sequence.
2020-07-02 · 0001493152-20-012424
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
2018-02-28 · 0001493152-18-002734
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B2 and confirms the priced prospectus.
2017-07-17 · 0001654954-17-006495
424B2 filed
Prospectus supplement
Prospectus supplement that can carry timing details without itself confirming imminent trading.
Follows 424B3 in the pre-IPO sequence.
2017-05-09 · 0001654954-17-004248
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2017-05-09 · 0001654954-17-004245
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2017-05-05 · 9999999995-17-001202
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B4 and marks the registration effective.
2017-05-05 · 9999999995-17-001200
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows 424B1 and confirms the priced prospectus.
2016-07-05 · 0001415889-16-006362
424B1 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2016-07-05 · 0001415889-16-006361
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2016-07-01 · 9999999995-16-005070
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B4 in the pre-IPO sequence.
2016-06-17 · 0001415889-16-006247
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2014-12-19 · 0001415889-14-003944
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2014-12-18 · 9999999995-14-003734
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2014-12-09 · 0001415889-14-003829
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior 8-A12B filing.
2014-12-02 · 0001415889-14-003773
8-A12B effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows S-1/A and registers the class of securities for exchange listing.
2014-11-26 · 0001415889-14-003711
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2014-11-26 · 0001415889-14-003705
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
2014-11-12 · 0001415889-14-003429
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows FWP and supplements the active offering with updated prospectus details.
2014-11-07 · 0001415889-14-003356
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows FWP and supplements the active offering with updated prospectus details.
2014-10-17 · 0001415889-14-003153
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1/A and supplements the active offering with updated prospectus details.
2014-10-10 · 0001415889-14-003047
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2014-10-07 · 0001415889-14-003015
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
2014-09-08 · 0001415889-14-002725
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2014-09-05 · 0001415889-14-002718
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2014-08-08 · 0001415889-14-002360
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
2014-07-08 · 0001415889-14-002081
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
2014-05-01 · 0001415889-14-001311
Comparable Deals

4 comparable deals

Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 4 using nearest neighbors.
+10.9%
Median day-1
50%
Above issue
+12.7%
Median week-1
-21.7%
Downside (p10)
Mobia Medical, Inc. MOBI
2026-05-08 $140M Day 1: -21.7% Wk 1: -19.7%
same SICrecent IPO
MiniMed Group, Inc. MMED
2026-03-06 $560M Day 1: -7.6% Wk 1: -17.3%
same SICrecent IPO
SpyGlass Pharma, Inc. SGP
2026-02-06 $150M Day 1: +65.0% Wk 1: +71.9%
same SICrecent IPO
Alamar Biosciences, Inc. ALMR
2026-04-17 $191M Day 1: +29.4% Wk 1: +42.8%
same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.